gp100 peptide YLEPGPVTA (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
gp100 peptide YLEPGPVTA (HLA-A*0201)

gp100 peptide YLEPGPVTA (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human melanoma antigen glycoprotein 100 (gp100) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: YLEPGPVTA
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

HCV NS3 peptide KLVALGINAV (HLA-A*0201)

HCV NS3 peptide KLVALGINAV (HLA-A*0201)

IBA Lifescience
Więcej
HERV-K Gag peptide VMAQSTQNV (HLA-A*0201)

HERV-K Gag peptide VMAQSTQNV (HLA-A*0201)

IBA Lifescience
Więcej
Fibromodulin F4 peptide YLLDLSYNHL (HLA-A*0201)

Fibromodulin F4 peptide YLLDLSYNHL (HLA-A*0201)

IBA Lifescience
Więcej